-
A GOOD INVESTMENT IN CANNABIS DISPENSARY
How to Invest in Cannabis? When entire countries legalize cannabis, new companies appear out of nowhere. Legalized recreational marijuana in early 2018. Within just two weeks, two dozen Los Angeles businesses received permission to sell recreational marijuana products. The cannabis dispensaries industry is growing very rapidly. Check over here for more details about hemp.
Points of sale (dispensaries) continue to receive a license to sell recreational products, there is a need to increase the volume of products from new enterprises. This is a growing industry and people are starting to see what can be earned here.
But what does this promise you, an interested investor? In fact, you have many options. There are a number of ways, both direct and indirect, to turn cannabis dispensaries into one of the most intriguing investments in your portfolio.
And of course, you are not alone in your doubts and concerns about this asset. None of the above is a recommendation.Cannabis dispensaries remains illegal under federal laws, which limits financial manipulation of this resource. In addition, while the industry is growing, the first-to-market shares of companies are not showing explosive growth. People who want to hit a big jackpot right away may not be able to do this. But if you believe in the potential of investing in cannabis and are ready for a long-term investment, here are a few investment areas.
MEDICAL CANNABIS, PRODUCTS AND COMPANIES
Cannabis stocks are a new and unusual investment destination. In trying to compare this to your typical traditional investment, you need to understand and be fully aware that marijuana is not a “safe bet”. But if you decide to take the risk, medical marijuana provides the most opportunities. Many more states have legalized medical cannabis than recreational cannabis dispensaries, and medical weed has been legal in Canada for nearly twenty years.
Medical cannabisSeveral investment options can be found on major stock exchanges in both the US and Canada - for example, GW Pharmaceuticals (GWPH - Get Report), whose epidiolex cannabidiol-based epilepsy drug was recently approved by the US Food and Drug Administration (FDA). ). However, in many cases, such stocks are traded on over-the-counter (OTC) markets, where securities and shares are traded through dealers, as opposed to centralized networks such as the NASDAQ.
First, do your research, find out where marijuana is legal, and decide if you plan on investing in medical cannabis or other types of drugs.
CANADIAN CANNABIS COMPANIES
Some of the named Canadian companies are interesting for their market performance. OrganiGram (OGRMF), a licensed medical marijuana grower, is showing good Q2 results at the time of this writing. As the number of patients using medical cannabis grows in the country, so does the sales of OrganiGram, which is in no small part due to the company’s production of cannabis oil.
Canopy Growth Corporation (TWMJF), a Canadian company that not only produces but also researches cannabis, is another popular investment option. It was recently valued at about $ 4.35 billion, and Bank of Montreal is helping the company with funding, which gives it a competitive edge. One of its main competitors, Aurora Cannabis (ACBFF), is expanding cannabis growing and has acquired a competitor called CanniMed Therapeutics.
The first cannabis company actually traded on a major U.S. exchange was Canada’s Cronos Group Inc. (CRON), which is listed on NASDAQ. By cultivating cannabis, like Aurora, among others, Cronos is expanding internationally. Stock volatility is what attracts people to this company; however, there are those who are scared away by this feature. This year, the company’s shares are generally declining, which, however, does not prevent the rate from jumping up to 14% on some days. Another Canadian company, Canopy Growth Corp. (CGC), recently traded on the NYSE.
Canadian cannabis companiesAnother milestone recently passed for Canadian marijuana stocks was the introduction of Tilray (TLRY), the first such company to make an initial public offering. Tilray, which advertises itself as a one-stop medical cannabis company, was valued at $ 17 per share, and quickly skyrocketed more than 21% after its IPO.
There are several other fairly well-known medical marijuana companies that you might want to take a look at, such as Med ReLeaf (MEDFF) and Aphria (APHQF).
Unfortunately, medical cannabis is not as widespread in our country, and the market does not match Canadian indicators. That is why people tend to find Canadian companies, of which there are many more.
CANNABIS AND CANNABIDIOL: RETAIL COMPANIES
Although recreational marijuana is much less common than medical marijuana, its approval rate is at the highest ever in public opinion polls on the subject. Cannabis, including recreational cannabis dispensaries, is 100% legal in nine American states and Washington, DC. Canada is close to legalizing recreational marijuana, and Prime Minister Justin Trudeau continues to announce plans to pass legislation in the summer of 2018.
Medical cannabis companies will certainly benefit from new customers, but this will also require additional costs to meet demand. This is important to remember: there is an opportunity to make money, but costs are inevitable. Not all cannabis stocks will be profitable just because cannabis is legalized.
Another interesting company to look out for has no public shares - yet. MedMen Enterprises is a highly successful cannabis retailer with dispensaries in several states. MedMen has announced that it plans to go public, and also announced its go-to-buy procedure for OpenPartner Media Corporation, which is currently not listed. It may be worth paying attention to the details and the planned timeline for the transformation into a public company.
EXCHANGE TRADED FUNDS
As stocks in marijuana companies become more common, specialized exchange-traded funds also come into use. They allow you to trade multiple securities in a single fund, ensuring portfolio diversification. These tempting tools appeared, however, even later than stocks of companies working with marijuana. So, if banks are still wary of stocks in individual cannabis-related companies, they will definitely be wary of fund stocks in several such companies.
So be on the lookout. The Horizons family of funds has a cannabis-related equity fund. The Horizons Marijuana Life Sciences ETF (HMMJ) fund is popular - it includes shares of the previously mentioned companies - Aurora and Canopy Growth.
ETFMG Alternative Harvest ETF (MJ - Get Report) is a fund that consists exclusively of stocks of marijuana-related companies, and the Evolve Marijuana ETF (TSX: SEED), which appeared a little later, consists almost entirely of shares of Canadian companies and is traded on the Toronto Stock Exchange …
Due to the fact that many well-known cannabis producers are based, dependence on Canadian companies and the economy is considered another risk factor for ETFs. If something happens to the Canadian economy, the shares of many Canadian companies will collapse at once.
HEMP GROWERS STOCK: INDUSTRIAL HEMP
Want to be one of the first to invest in the industry and profit from cannabis? If you want to invest directly in cannabis dispensaries production, the opportunity exists.
Founded in 2008, Hemp Inc. (HEMP) aims to become a one-stop cannabis business, including growing, extracting ingredients, processing fibers, even selling hemp care products. The hemp grower may have an important milestone as Senate Majority Leader Mitch McConnell recently announced the pending bill that, if passed, would legitimize industrial hemp at the federal level. If the bill passes, a company like Hemp Inc., which has been around for a long time, is likely to gain an edge over its competitors.
How to invest in stocks of companies dealing with marijuana in 2018, while minimizing risks?
A smart bet when dealing with a marijuana investment may be to find shares in a company for which cannabis is only part of its business, or even only indirectly related to its business.
For example, Abbvie Inc. (ABBV - Get Report), is a conventional pharmaceutical company. However, it sells, among other things, Marinol, a FDA-approved synthetic cannabinoid designed to prevent nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY - Get Report) is a pharmaceutical company licensed to sell synthetic cannabis by the US Drug Enforcement Administration (DEA), even though it has donated funds to an anti-marijuana legalization group in the past.
subscribe via RSS